传导性听力损失与痴呆相关:All of Us研究项目
该横断面研究基于NIH All of Us项目≥18岁参与者338,048人,发现双侧传导性听力损失(CHL,ICD-10 H90.0)与痴呆(ICD-10 F03、G30-32)存在独立关联,校正混杂因素后痴呆风险增加约2倍(OR=2.05,95%CI 1.18-3.32,P=0.006)。加入手术或助听装置后关联略减弱,提示CHL治疗对痴呆风险影响有限。
要点
- 传导性听力损失者痴呆风险约为无CHL者的2倍(OR=2.05)。
- 校正手术或助听装置后,关联仅轻微减弱(OR分别2.03、1.98)。
- CHL为纯外周性听力损失,该关联不支持痴呆导致听力下降的反向因果。
核心结论
- 在All of Us研究项目中,传导性听力损失与痴呆存在强关联,手术和非手术治疗仅轻微降低痴呆风险。
研究设计与样本
- 横断面研究,纳入NIH All of Us研究项目≥18岁自愿参与者338,048人。
- 暴露为ICD-10编码H90.0定义的双侧传导性听力损失,结局为ICD-10编码F03、G30-32定义的痴呆。
- 采用多变量回归评估痴呆风险比,校正年龄、性别、族裔、种族、教育、吸烟史及CHL手术和医疗干预。
主要发现
- 参与者平均年龄54岁(标准差17),女性占62.9%(n=212,623)。
- 队列中393人(0.1%)有传导性听力损失,6,597人(1.9%)患痴呆。
- 校正协变量后,CHL组痴呆风险比为2.05(95%CI 1.18-3.32;P=0.006)。
- 加入手术干预(镫骨切除术、鼓室成形术、乳突切除术、鼓膜修补术)后OR=2.03(95%CI 1.17-3.29;P=0.007)。
- 加入助听装置(助听器、植入物)后OR=1.98(95%CI 1.13-3.21;P=0.010)。
临床怎么用
- 对传导性听力损失患者应关注认知功能与痴呆风险筛查。
- 传导性听力损失的手术或助听装置治疗对痴呆风险的降低作用有限。
局限性
- 横断面设计无法确定传导性听力损失与痴呆的因果关系。
- 暴露与结局均基于ICD-10编码,可能存在错分偏倚。
- 传导性听力损失患者仅393例(0.1%),样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sensorineural hearing loss (SNHL) has been associated with cognitive impairment and dementia. However, because SNHL contains a neural component, it is difficult to completely exclude reverse causation whereby dementia causes worse SNHL. Conductive hearing loss (CHL), a purely peripheral phenomenon, would not have this mechanistic connection. We investigate the association between CHL and dementia in a large national cohort. METHODS: Cross-sectional study of ≥ 18-year-old (n = 338,048) voluntary participants from the NIH All of Us Research Program. The exposure was bilateral CHL defined by ICD-10 code (H90.0). The outcome was dementia defined by ICD-10 codes (F03, G30-32). The odds of dementia in subjects with and without CHL were assessed with multivariable regression, controlling for potentially confounding variables (age, sex, ethnicity, race, education, and smoking history), as well as surgical and medical interventions for CHL. RESULTS: The mean (SD, range) age was 54 years (±17). 62.9% (n = 212,623) of participants identified as female. The cohort included 393 (0.1%) individuals with CHL. 1.9% (n = 6597) had dementia. After controlling for covariates, the odds of dementia were 2.05 times (95% CI 1.18-3.32; p = 0.006) higher for those with CHL compared to those without CHL. The odds were variably reduced when surgical interventions (stapedectomy, tympanoplasty, mastoidectomy, myringoplasty) (OR = 2.03, CI 1.17-3.29; p = 0.007) or hearing devices (hearing aids, implants) (OR = 1.98, CI 1.13-3.21; p = 0.010) were added to the fully adjusted multivariable model. CONCLUSION: In the All of Us Research Program, CHL was strongly associated with dementia and treatment of CHL, both surgically and non-surgically, minimally reduced the odds of dementia.
引用
- Weinstein HNW, Tucker LH, Denham MW, et al. Conductive Hearing Loss is Associated With Dementia in the All of Us Research Program. Laryngoscope. 2026. PMID: 41957530. doi:10.1002/lary.70546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。